An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma

被引：93

作者：

Samama, Meyer Michel ^{[1
,2
]}

Amiral, Jean ^{[3
]}

Guinet, Celine ^{[1
]}

Perzborn, Elisabeth ^{[4
]}

Depasse, Francois ^{[1
]}

机构：

[1] Biomnis, Labs R&D, F-94208 Ivry, France

[2] Univ Hosp, Hotel Dieu, Paris, France

[3] HyphenBiomed, Neuville Sur Oise, France

[4] Bayer HealthCare, Wuppertal, Germany

来源：

THROMBOSIS AND HAEMOSTASIS | 2010年 / 104卷 / 05期

关键词：

PHARMACOKINETICS; PHARMACODYNAMICS; HEPARIN;

D O I：

10.1160/TH10-03-0204

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1078 / 1079

页数：2

共 9 条

[1] ASMIS IM, 2010, HAEMOSTASCOLOGIE, V30
[2] Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra®) anti-Xa activity
Depasse, F
Gerotziafas, GT
Busson, J
Van Dreden, P
Samama, MM
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (02) : 346 - 348
[3] HIRSH J, 1992, CHEST, V102, pS337, DOI 10.1378/chest.102.4_Supplement.337S
[4] Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor
Kubitza, D
Becka, M
Voith, B
Zuehlsdorf, M
Wensing, G
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (04) : 412 - 421
[5] Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
Laux, Volker
Perzborn, Elisabeth
Heitmeier, Stefan
von Degenfeld, Georges
Dittrich-Wengenroth, Elke
Buchmueller, Anja
Gerdes, Christoph
Misselwitz, Frank
[J]. THROMBOSIS AND HAEMOSTASIS, 2009, 102 (05) : 892 - 899
[6] Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement
Mueck, Wolfgang
Borris, Lars C.
Dahl, Ola E.
Haas, Sylvia
Huisman, MennoV.
Kakkar, Ajay K.
Kalebo, Peter
Muelhofer, Eva
Misselwitz, Frank
Eriksson, Bengt I.
[J]. THROMBOSIS AND HAEMOSTASIS, 2008, 100 (03) : 453 - 461
[7] Assessment of laboratory assays to measure rivaroxaban - an oral, direct factor Xa inhibitor
Samama, Meyer Michel
Martinoli, Jean-Luc
LeFlem, Lena
Guinet, Celine
Plu-Bureau, Genevieve
Depasse, Francois
Perzborn, Elisabeth
[J]. THROMBOSIS AND HAEMOSTASIS, 2010, 103 (04) : 815 - 825
[8] New oral anticoagulants in atrial fibrillation
Turpie, Alexander G. G.
[J]. EUROPEAN HEART JOURNAL, 2008, 29 (02) : 155 - 165
[9] Weitz JI, 2008, CHEST, V134, P473

← 1 →